N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide (Compound)

Pubchem:PUBCHEM:53239561

Id:b8ddbcd8-9914-55e7-aa51-597ec2677574

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide.

Results found

Linked to

	Label	Description
	N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 8 subunit alpha Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 4 subunit alpha Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 2 subunit alpha Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 10 subunit alpha Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 1 subunit alpha Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 9 subunit alpha Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 3 subunit alpha Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 5 subunit alpha Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide bioactivity Sodium channel protein type 8 subunit alpha

Knowledge Graph Assertion (Entity type)